JP2015512876A5 - - Google Patents

Info

Publication number

JP2015512876A5

JP2015512876A5 JP2014557620A JP2014557620A JP2015512876A5 JP 2015512876 A5 JP2015512876 A5 JP 2015512876A5 JP 2014557620 A JP2014557620 A JP 2014557620A JP 2014557620 A JP2014557620 A JP 2014557620A JP 2015512876 A5 JP2015512876 A5 JP 2015512876A5

Authority

JP

Japan

Prior art keywords

amino acid

seq

factor viii

fusion protein

xten

Prior art date

2012-07-11

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Granted

Links

• Espacenet
• Global Dossier
• Discuss

• 229960000301 factor viii Drugs 0.000 claims description 282
• 102000001690 Factor VIII Human genes 0.000 claims description 272
• 108010054218 Factor VIII Proteins 0.000 claims description 272
• 235000001014 amino acid Nutrition 0.000 claims description 258
• 150000001413 amino acids Chemical class 0.000 claims description 234
• 102000037865 fusion proteins Human genes 0.000 claims description 186
• 108020001507 fusion proteins Proteins 0.000 claims description 186
• 108090000765 processed proteins & peptides Proteins 0.000 claims description 104
• 229920001184 polypeptide Polymers 0.000 claims description 101
• 102000004196 processed proteins & peptides Human genes 0.000 claims description 101
• 101000911390 Homo sapiens Coagulation factor VIII Proteins 0.000 claims description 50
• 102000057593 human F8 Human genes 0.000 claims description 39
• 229960000900 human factor viii Drugs 0.000 claims description 33
• 239000012634 fragment Substances 0.000 claims description 27
• 230000002947 procoagulating effect Effects 0.000 claims description 20
• 102000002110 C2 domains Human genes 0.000 claims description 19
• 108050009459 C2 domains Proteins 0.000 claims description 19
• 150000007523 nucleic acids Chemical class 0.000 claims description 14
• 206010053567 Coagulopathies Diseases 0.000 claims description 12
• 108020004707 nucleic acids Proteins 0.000 claims description 12
• 102000039446 nucleic acids Human genes 0.000 claims description 12
• 239000008194 pharmaceutical composition Substances 0.000 claims description 12
• 102100026735 Coagulation factor VIII Human genes 0.000 claims description 11
• 201000003542 Factor VIII deficiency Diseases 0.000 claims description 10
• 208000009292 Hemophilia A Diseases 0.000 claims description 10
• 238000000034 method Methods 0.000 claims description 10
• 235000018102 proteins Nutrition 0.000 claims description 9
• 102000004169 proteins and genes Human genes 0.000 claims description 9
• 108090000623 proteins and genes Proteins 0.000 claims description 9
• DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 8
• 210000004027 cell Anatomy 0.000 claims description 7
• 230000004927 fusion Effects 0.000 claims description 7
• 238000005215 recombination Methods 0.000 claims description 7
• 230000006798 recombination Effects 0.000 claims description 7
• 208000032843 Hemorrhage Diseases 0.000 claims description 5
• 208000034158 bleeding Diseases 0.000 claims description 5
• 230000000740 bleeding effect Effects 0.000 claims description 5
• 239000004471 Glycine Substances 0.000 claims description 4
• QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims description 4
• 239000002253 acid Substances 0.000 claims description 4
• 235000004279 alanine Nutrition 0.000 claims description 4
• 208000015294 blood coagulation disease Diseases 0.000 claims description 4
• 230000009852 coagulant defect Effects 0.000 claims description 4
• 239000003937 drug carrier Substances 0.000 claims description 3
• 238000004519 manufacturing process Methods 0.000 claims description 3
• 208000024891 symptom Diseases 0.000 claims description 3
• 238000012258 culturing Methods 0.000 claims description 2
• FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 136
• -1 SEQ ID NO: 2 amino acid Chemical class 0.000 claims 26
• GOJUJUVQIVIZAV-UHFFFAOYSA-N 2-amino-4,6-dichloropyrimidine-5-carbaldehyde Chemical group NC1=NC(Cl)=C(C=O)C(Cl)=N1 GOJUJUVQIVIZAV-UHFFFAOYSA-N 0.000 claims 3
• 108091028043 Nucleic acid sequence Proteins 0.000 claims 2
• 102000009027 Albumins Human genes 0.000 claims 1
• 108010088751 Albumins Proteins 0.000 claims 1
• 101800001415 Bri23 peptide Proteins 0.000 claims 1
• 101800000655 C-terminal peptide Proteins 0.000 claims 1
• 102400000107 C-terminal peptide Human genes 0.000 claims 1
• 102000011022 Chorionic Gonadotropin Human genes 0.000 claims 1
• 108010062540 Chorionic Gonadotropin Proteins 0.000 claims 1
• 108700028146 Genetic Enhancer Elements Proteins 0.000 claims 1
• 108700007698 Genetic Terminator Regions Proteins 0.000 claims 1
• 108060003951 Immunoglobulin Proteins 0.000 claims 1
• 102000018071 Immunoglobulin Fc Fragments Human genes 0.000 claims 1
• 108010091135 Immunoglobulin Fc Fragments Proteins 0.000 claims 1
• 102100029832 Reticulon-3 Human genes 0.000 claims 1
• 102000004338 Transferrin Human genes 0.000 claims 1
• 108090000901 Transferrin Proteins 0.000 claims 1
• 241000700605 Viruses Species 0.000 claims 1
• 239000003623 enhancer Substances 0.000 claims 1
• 229940084986 human chorionic gonadotropin Drugs 0.000 claims 1
• 102000018358 immunoglobulin Human genes 0.000 claims 1
• 238000001727 in vivo Methods 0.000 claims 1
• 239000002245 particle Substances 0.000 claims 1
• 239000013612 plasmid Substances 0.000 claims 1
• 108010094020 polyglycine Proteins 0.000 claims 1
• 229920000232 polyglycine polymer Polymers 0.000 claims 1
• 108010000222 polyserine Chemical group 0.000 claims 1
• 230000003362 replicative effect Effects 0.000 claims 1
• 239000012581 transferrin Substances 0.000 claims 1
• 241000701161 unidentified adenovirus Species 0.000 claims 1
• 241000701447 unidentified baculovirus Species 0.000 claims 1
• 125000000539 amino acid group Chemical group 0.000 description 46
• 238000003780 insertion Methods 0.000 description 19
• 230000037431 insertion Effects 0.000 description 19
• 125000006850 spacer group Chemical group 0.000 description 17
• 230000002378 acidificating effect Effects 0.000 description 16
• 238000003556 assay Methods 0.000 description 13
• 230000002829 reductive effect Effects 0.000 description 11
• 238000000338 in vitro Methods 0.000 description 10
• 230000035602 clotting Effects 0.000 description 8
• 108010094028 Prothrombin Proteins 0.000 description 6
• 239000008280 blood Substances 0.000 description 6
• 210000004369 blood Anatomy 0.000 description 6
• 238000003776 cleavage reaction Methods 0.000 description 6
• AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 6
• 239000000203 mixture Substances 0.000 description 6
• 230000007017 scission Effects 0.000 description 6
• 108010000499 Thromboplastin Proteins 0.000 description 5
• 102000002262 Thromboplastin Human genes 0.000 description 5
• 230000015271 coagulation Effects 0.000 description 5
• 238000005345 coagulation Methods 0.000 description 5
• BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 5
• 230000000295 complement effect Effects 0.000 description 4
• 229940124135 Factor VIII inhibitor Drugs 0.000 description 3
• MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 3
• 238000004458 analytical method Methods 0.000 description 3
• 230000002950 deficient Effects 0.000 description 3
• 238000012217 deletion Methods 0.000 description 3
• 230000037430 deletion Effects 0.000 description 3
• 239000013604 expression vector Substances 0.000 description 3
• 102100023804 Coagulation factor VII Human genes 0.000 description 2
• 108010023321 Factor VII Proteins 0.000 description 2
• 108010080805 Factor XIa Proteins 0.000 description 2
• 241000699666 Mus <mouse, genus> Species 0.000 description 2
• 108091005804 Peptidases Proteins 0.000 description 2
• 239000004365 Protease Substances 0.000 description 2
• AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 2
• 239000004473 Threonine Substances 0.000 description 2
• 230000001112 coagulating effect Effects 0.000 description 2
• 230000001186 cumulative effect Effects 0.000 description 2
• 230000003247 decreasing effect Effects 0.000 description 2
• 230000001747 exhibiting effect Effects 0.000 description 2
• 229940012413 factor vii Drugs 0.000 description 2
• 102000040430 polynucleotide Human genes 0.000 description 2
• 108091033319 polynucleotide Proteins 0.000 description 2
• 239000002157 polynucleotide Substances 0.000 description 2
• 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
• 239000003805 procoagulant Substances 0.000 description 2
• 238000000159 protein binding assay Methods 0.000 description 2
• 238000006467 substitution reaction Methods 0.000 description 2
• 125000001433 C-terminal amino-acid group Chemical group 0.000 description 1
• 102100027995 Collagenase 3 Human genes 0.000 description 1
• 238000002965 ELISA Methods 0.000 description 1
• 238000012286 ELISA Assay Methods 0.000 description 1
• 108010029144 Factor IIa Proteins 0.000 description 1
• 108010048049 Factor IXa Proteins 0.000 description 1
• 108010054265 Factor VIIa Proteins 0.000 description 1
• 108010074864 Factor XI Proteins 0.000 description 1
• 108010074860 Factor Xa Proteins 0.000 description 1
• WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
• 101000577887 Homo sapiens Collagenase 3 Proteins 0.000 description 1
• 108060005987 Kallikrein Proteins 0.000 description 1
• 102000001399 Kallikrein Human genes 0.000 description 1
• COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
• 102100027998 Macrophage metalloelastase Human genes 0.000 description 1
• 101710187853 Macrophage metalloelastase Proteins 0.000 description 1
• 241000124008 Mammalia Species 0.000 description 1
• 102100030219 Matrix metalloproteinase-17 Human genes 0.000 description 1
• 108090000585 Matrix metalloproteinase-17 Proteins 0.000 description 1
• 102100029693 Matrix metalloproteinase-20 Human genes 0.000 description 1
• 108090000609 Matrix metalloproteinase-20 Proteins 0.000 description 1
• 241000699670 Mus sp. Species 0.000 description 1
• 102100033174 Neutrophil elastase Human genes 0.000 description 1
• 102000035195 Peptidases Human genes 0.000 description 1
• ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
• 108010076504 Protein Sorting Signals Proteins 0.000 description 1
• 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 1
• 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 1
• 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
• 108090000190 Thrombin Proteins 0.000 description 1
• 101000889850 Xenopus laevis Testin Proteins 0.000 description 1
• 230000004913 activation Effects 0.000 description 1
• 210000004899 c-terminal region Anatomy 0.000 description 1
• 239000006143 cell culture medium Substances 0.000 description 1
• 230000001413 cellular effect Effects 0.000 description 1
• 150000001875 compounds Chemical class 0.000 description 1
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
• 229940079593 drug Drugs 0.000 description 1
• 239000003814 drug Substances 0.000 description 1
• 230000000694 effects Effects 0.000 description 1
• 229940012414 factor viia Drugs 0.000 description 1
• 229940003169 factor viii / von willebrand factor Drugs 0.000 description 1
• 235000013922 glutamic acid Nutrition 0.000 description 1
• 239000004220 glutamic acid Substances 0.000 description 1
• ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
• 230000023597 hemostasis Effects 0.000 description 1
• 238000000099 in vitro assay Methods 0.000 description 1
• 239000003112 inhibitor Substances 0.000 description 1
• 230000002401 inhibitory effect Effects 0.000 description 1
• 108090000155 pancreatic elastase II Proteins 0.000 description 1
• 230000036961 partial effect Effects 0.000 description 1
• COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
• 230000003252 repetitive effect Effects 0.000 description 1
• 108091008146 restriction endonucleases Proteins 0.000 description 1
• 229960004072 thrombin Drugs 0.000 description 1
• 108010047303 von Willebrand Factor Proteins 0.000 description 1
• 102100036537 von Willebrand factor Human genes 0.000 description 1
• 229960001134 von willebrand factor Drugs 0.000 description 1